 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on Dec 21, 2020 |
| Title |
Selective Vulnerability to Pyrimidine Starvation in Hematologic Malignancies Revealed by AG-636, a Novel Clinical-Stage Inhibitor of Dihydroorotate Dehydrogenase |
| Organism |
Homo sapiens |
| Experiment type |
Other
|
| Summary |
Agents targeting metabolic pathways form the backbone of standard oncology treatments, though a better understanding of differential metabolic dependencies could instruct more rationale-based therapeutic approaches. We performed a chemical biology screen that revealed a strong enrichment in sensitivity to a novel dihydroorotate dehydrogenase (DHODH) inhibitor, AG-636, in cancer cell lines of hematologic versus solid tumor origin. Differential AG-636 activity translated to the in vivo setting. Dissection of the relationship between uridine availability and response to AG-636 revealed a divergent ability of lymphoma and solid tumor cell lines to survive and grow in the setting of depleted extracellular uridine and DHODH inhibition. Metabolic characterization paired with unbiased functional genomic and proteomic screens pointed to adaptive mechanisms to cope with nucleotide stress as contributing to response to AG-636. These findings support targeting of DHODH in lymphoma and other hematologic malignancies and suggest combination strategies aimed at interfering with DNA damage response pathways.
|
| |
|
| Overall design |
A genome-wide CRISPR depletion screen was performed in A549 cells with or without AG-636 to identify specific genes and pathways limiting response to AG-636. Uridine was provided in the medium at a concentration of 5 µM, resulting in alternate periods of uridine availability and depletion over the course of the culture period.
|
| |
|
| Contributor(s) |
McDonald G, Ulanet D, Fan ZP |
| Citation(s) |
33082276 |
| |
| Submission date |
Apr 15, 2020 |
| Last update date |
Mar 22, 2021 |
| Contact name |
Zi Peng Fan |
| E-mail(s) |
rds.subscription@agios.com
|
| Phone |
6178446724
|
| Organization name |
Agios Pharmaceuticals
|
| Street address |
88 Sidney Street
|
| City |
Cambridge |
| State/province |
MA |
| ZIP/Postal code |
02139 |
| Country |
USA |
| |
|
| Platforms (1) |
|
| Samples (24)
|
| GSM4476697 |
A549 cells, Module 1 Time 0 replicate 2 |
| GSM4476698 |
A549 cells, Module 1 Time 0 replicate 3 |
| GSM4476699 |
A549 cells, Module 1 Time End Treated replicate 1 |
| GSM4476700 |
A549 cells, Module 1 Time End Treated replicate 2 |
| GSM4476701 |
A549 cells, Module 1 Time End Treated replicate 3 |
| GSM4476702 |
A549 cells, Module 1 Time End Untreated replicate 1 |
| GSM4476703 |
A549 cells, Module 1 Time End Untreated replicate 2 |
| GSM4476704 |
A549 cells, Module 1 Time End Untreated replicate 3 |
| GSM4476705 |
A549 cells, Module 2 Time 0 replicate 2 |
| GSM4476706 |
A549 cells, Module 2 Time 0 replicate 3 |
| GSM4476707 |
A549 cells, Module 2 Time End Treated replicate 1 |
| GSM4476708 |
A549 cells, Module 2 Time End Treated replicate 2 |
| GSM4476709 |
A549 cells, Module 2 Time End Treated replicate 3 |
| GSM4476710 |
A549 cells, Module 2 Time End Untreated replicate 1 |
| GSM4476711 |
A549 cells, Module 2 Time End Untreated replicate 2 |
| GSM4476712 |
A549 cells, Module 2 Time End Untreated replicate 3 |
| GSM4476713 |
A549 cells, Module 3 Time 0 replicate 2 |
| GSM4476714 |
A549 cells, Module 3 Time 0 replicate 3 |
| GSM4476715 |
A549 cells, Module 3 Time End Treated replicate 1 |
| GSM4476716 |
A549 cells, Module 3 Time End Treated replicate 2 |
| GSM4476717 |
A549 cells, Module 3 Time End Treated replicate 3 |
| GSM4476718 |
A549 cells, Module 3 Time End Untreated replicate 1 |
| GSM4476719 |
A549 cells, Module 3 Time End Untreated replicate 2 |
| GSM4476720 |
A549 cells, Module 3 Time End Untreated replicate 3 |
|
| Relations |
| BioProject |
PRJNA625433 |
| SRA |
SRP256432 |
| Supplementary file |
Size |
Download |
File type/resource |
| GSE148688_RAW.tar |
13.8 Mb |
(http)(custom) |
TAR (of TXT) |
SRA Run Selector |
| Raw data are available in SRA |
| Processed data provided as supplementary file |
|
|
|
|
 |
Less...
More...